Literature DB >> 23959535

Strengthening the bones in primary biliary cirrhosis.

Paul Angulo1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23959535      PMCID： PMC3856251          DOI： 10.1002/hep.26696

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  17 in total

Review 1.  Assessment of fracture risk.

Authors:  John A Kanis; Frederik Borgstrom; Chris De Laet; Helena Johansson; Olof Johnell; Bengt Jonsson; Anders Oden; Niklas Zethraeus; Bruce Pfleger; Nikolai Khaltaev
Journal:  Osteoporos Int       Date:  2004-12-23       Impact factor: 4.507

2.  Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis.

Authors:  J E Springer; D E Cole; L A Rubin; K Cauch-Dudek; L Harewood; J Evrovski; V D Peltekova; E J Heathcote
Journal:  Gastroenterology       Date:  2000-01       Impact factor: 22.682

3.  Bone disease in primary biliary cirrhosis: independent indicators and rate of progression.

Authors:  K V Menon; P Angulo; S Weston; E R Dickson; K D Lindor
Journal:  J Hepatol       Date:  2001-09       Impact factor: 25.083

4.  Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis.

Authors:  Núria Guañabens; Albert Parés; Inmaculada Ros; Llorenç Caballería; Francesca Pons; Sergi Vidal; Ana Monegal; Pilar Peris; Juan Rodés
Journal:  J Hepatol       Date:  2005-01-13       Impact factor: 25.083

5.  Osteoporosis in primary biliary cirrhosis revisited.

Authors:  J Newton; R Francis; M Prince; O James; M Bassendine; D Rawlings; D Jones
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

6.  Bone loss in primary biliary cirrhosis: absence of association with severity of liver disease.

Authors:  Laurence Le Gars; Caroline Grandpierre; Olivier Chazouillères; Francis Berenbaum; Raoul Poupon
Journal:  Joint Bone Spine       Date:  2002-03       Impact factor: 4.929

7.  Osteoporosis: still a typical complication of primary biliary cirrhosis?

Authors:  E Solerio; G Isaia; R Innarella; M Di Stefano; M Farina; E Borghesio; L Framarin; M Rizzetto; F Rosina
Journal:  Dig Liver Dis       Date:  2003-05       Impact factor: 4.088

8.  Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis.

Authors:  Núria Guañabens; Anna Monegal; Dacia Cerdá; África Muxí; Laia Gifre; Pilar Peris; Albert Parés
Journal:  Hepatology       Date:  2013-10-29       Impact factor: 17.425

9.  Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis.

Authors:  Nuria Guañabens; Albert Parés; Inmaculada Ros; Luisa Alvarez; Francesca Pons; Llorenç Caballería; Ana Monegal; M Jesus Martínez de Osaba; Merce Roca; Pilar Peris; Juan Rodés
Journal:  Am J Gastroenterol       Date:  2003-10       Impact factor: 10.864

10.  Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures.

Authors:  D Marshall; O Johnell; H Wedel
Journal:  BMJ       Date:  1996-05-18
View more
  2 in total

1.  Primary biliary cirrhosis degree assessment by acoustic radiation force impulse imaging and hepatic fibrosis indicators.

Authors:  Hai-Chun Zhang; Rong-Fei Hu; Ting Zhu; Ling Tong; Qiu-Qin Zhang
Journal:  World J Gastroenterol       Date:  2016-06-14       Impact factor: 5.742

2.  Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment.

Authors:  Adriano L Spirlandeli; Ingrid Dick-de-Paula; Ariane Zamarioli; Vanda Jorgetti; Leandra N Z Ramalho; Marcello H Nogueira-Barbosa; Jose B Volpon; Alceu A Jordão; Fernando Q Cunha; Sandra Y Fukada; Francisco J A de Paula
Journal:  Clinics (Sao Paulo)       Date:  2017-04       Impact factor: 2.365
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.